駱志國，男，漢族，1973年6月生，教授、主任醫(yī)師、黨員，博士研究生學(xué)歷，碩士研究生導(dǎo)師?，F(xiàn)任十堰市太和醫(yī)院（湖北醫(yī)藥學(xué)院附屬太和醫(yī)院）腫瘤防治中心主任，腫瘤防治中心黨支部書記。湖北省抗癌協(xié)會常務(wù)理事、湖北省抗癌協(xié)會肺癌專業(yè)委員會副主任委員、湖北省抗癌協(xié)會淋巴瘤專業(yè)委員會副主任委員、湖北省抗癌協(xié)會青年委員會副主任委員、十堰市抗癌協(xié)會理事長。湖北省“五四”青年獎?wù)芦@得者、湖北醫(yī)藥學(xué)院教學(xué)園丁獎獲得者。主要從事腫瘤的早期診斷、治療、研究與教學(xué)工作，主要研究方向為以放療為中心的腫瘤綜合治療、腫瘤放射抗拒和化療耐藥的分子機制，主持自然科學(xué)基金青年基金項目、湖北省衛(wèi)生廳核心項目、湖北省教育廳青年人才項目等重大項目的課題研究。2011年，參與研究《褪黑素抗腫瘤血管生成作用》，獲得十堰市科技進(jìn)步一等獎（排名第三）。2015年，主持《胃癌侵襲與轉(zhuǎn)移的機制及防治》研究，獲得十堰市科技進(jìn)步二等獎（排名）。2016年，主持《胃癌侵襲與轉(zhuǎn)移的機制及防治》研究，獲得湖北省科技進(jìn)步三等獎（排名）。目前已在期刊發(fā)表論文22篇，其中SCI論文14篇。ProfessorZhiguoLuo，Ph.D.，BranchDirector，DepartmentofOncology，TaiheHospital，Shiyan，Hubei，China.ComprehensiveTreatmentofTumorandMechanismsonRadio-/Chemo-therapyResistance.EDUCATIOND.Sc.andM.Sc.(RadiationOncology):WuhanUniversity，2001-2006.B.Sc.(ClinicalMedicine):HubeiUniversityofMedicine，1993-1998.WORKINGEXPERIENCE2016-，Professor，F(xiàn)irstClinicalCollege，HubeiUniversityofMedicine;BranchDirector，DepartmentofOncology，TaiheHospital.2006-2016，AssociateProfessor，F(xiàn)irstClinicalCollege，HubeiUniversityofMedicine;BranchDirector，DepartmentofOncology，TaiheHospital.1998-2001，Assistant，F(xiàn)irstClinicalCollege，HubeiUniversityofMedicine;AttendingDoctor，DepartmentofOncology，TaiheHospital.AWARDSANDHONORSFirstPrizeofShiyanScienceandTechnologyProgressAward(2012)SecondPrizeofShiyanScienceandTechnologyProgressAward(2015)ThirdPrizeofHubeiScienceandTechnologyProgressAward(2016)HubeiProvince“May4th”YouthMedalHubeiUniversityofMedicineTeachinggardenerAwardACADEMICSERVICEExecutiveDirector，HubeiAnti-cancerAssociationViceDeputyDirector，CommitteeofLungCancer，HubeiAnti-cancerAssociationViceDeputyDirector，CommitteeofMalignantlymphoma，HubeiAnti-cancerAssociationSELECTEDPUBLICATIONS1.ZhongYH，LiaoZK，ZhouFX，XieCH，XiaoCY，PanDF，LuoZG，LiuSQ，ZhouYF.Relationshipbetweentelomerelengthandradiosensitivityinvaroushumancancercelllines.BiochemBiophysResCommun.2008，367(1):84-89.(IF=2.406)2.KeQ，WuJ，MingB，ZhuS，YuM，WangY，HuC，XuS，LuoZG(correspondingauthor).IdentificationofthePAG1geneasanoveltargetofinherentradioresistanceinhumanlaryngealcarcinomacells.CancerBiotherRadiopharm.2012Dec;27(10):678-84.3.ZhuSM，XieL，ZhengH，QinF，LiuM，LuoZG(correspondingauthor)，WangY.ExperimentalstudyonA549celldeathmediatedbyxenoantigenα-gal?inhumanserum.ZhongguoFeiAiZaZhi.2012Nov;15(11):630-7.4.HanY，YuanJ，LuoZG，ZhaoJ，WuJ，LiuR，LopezV.DeterminantsofhopelessnessanddepressionamongChinesehospitalizedesophagealcancerpatientsandtheirfamilycaregivers.Psychooncology.2013Nov;22(11):2529-36.5.SongS1，ZhuS，ZhangZ，MoZ，KeQ，LuoZG(correspondingauthor).AstudyontheinhibitoryeffectofmatrineongastriccancerSGC-7901cells.AfrJTraditComplementAlternMed.2013Oct3;10(6):435-8.6.LuoZG，DongX，KeQ，DuanQ，ShenL.DownregulationofCD147bychitooligosaccharideinhibitsMMP-2expressionandsuppressesthemetastaticpotentialofhumangastriccancer.OncolLett.2014Jul;8(1):361-366.7.LuoZG，DongX，KeQ，DuanQ，ShenL.Chitooligosaccharidesinhibitethanol-inducedoxidativestressviaactivationofNrf2andreductionofMAPKphosphorylation.OncolRep.2014Nov;32(5):2215-22.8.HanY，HuD，LiuY，CaihongLu，LuoZG，ZhaoJ，LopezV，MaoJ.CopingstylesandsocialsupportamongdepressedChinesefamilycaregiversofpatientswithesophagealcancer.EurJOncolNurs.2014Sep25.9.ShenL，YuM，XuX，GaoL，NiJ，LuoZG(co-correspondingauthor)，WuS.Knockdownofβ3GnT8reverses5?fluorouracilresistanceinhumancolorectalcancercellsviainhibitionthebiosynthesisofpolylactosamine?typeN?glycans.IntJOncol.2014Dec;45(6):2560-8.10.HuJ，PanJ，LuoZG，TaoZ.DownregulationofSurvivinbyshRNnhibitsInvasionandEnhancestheRadiosensitivityofLaryngealSquamousCellCarcinoma.CellBiochemBiophys.2015Feb21.11.ZhuS，WangJ，XieB，LuoZG(co-correspondingauthor)，LinX，LiaoDJ.CultureataHigherTemperatureMildlyInhibitsCancerCellGrowthbutEnhancesChemotherapeuticEffectsbyInhibitingCell-CellCollaboration.PLoSOne.2015Oct23;10(10).12.DuanQ，LiuJ，LuoZG(correspondingauthor)，HuC.Postoperativebrachytherapyandelectronbeamirradiationforkeloids:Asingleinstitutionretrospectiveysis.MolClinOncol.2015;3(3):550-554.13.ShenL，DongXX，WuJB，QiuL，DuanQW，LuoZG(correspondingauthor).Radiosensitisationofhumangliomacellsbyinhibitionofβ1，6-GlcNAcbranchedN-glycans.TumourBiol.2016Apr;37(4):4909-18.<?xml:namespaceprefix="o"></?xml:namespace>